MS prevalence has doubled since 2000, driven by better diagnostics and longer life expectancy. However, researchers warn of significant inequalities, with patients in deprived areas facing higher mortality and delayed care.
0%
MS prevalence has doubled since 2000, driven by better diagnostics and longer life expectancy. However, researchers warn of significant inequalities, with patients in deprived areas facing higher mortality and delayed care.
